Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 46Unknown 8Terminated 4Recruiting 3Approved for marketing 3Withdrawn 1Suspended 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Pemetrexed 2trilaciclib 1trastuzumab deruxtecan 1pembrolizumab 1lorlatinib 1aumolertinib 1Gemcitabine 1Cisplatin 1Carboplatin 1Anterior Temporal Lobectomy 1Afatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Carcinoma, Non-Small-Cell Lung × Afatinib × Clear all
NCT06759857 2025-01-06

FHND9041

Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.

Phase 3 Enrolling by invitation
350 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡